0

    530697

    ZENLABS

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Zenlabs Ethica Limited Share Price Today

    Investment Returns

    Over 1 Month -20.36% Over 3 Months 19.67% Over 6 Months 46.96% Over 1 Year -11.35%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Zenlabs Ethica Limited fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 18.90
    • P/E Ratio (TTM) -9.55
    • Beta 1.24
    • Book Value / share 13.07
    • Return on equity 2.63%
    • EPS (TTM) 0.03
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.00
    info icon alternate text

    Zenlabs Ethica Limited Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 10.58
    Operating Expense 10.62
    Net Profit 0.00
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.00
    EBITDA 0.40
    Effective Tax Rate (%) 100.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 12.43
    Operating Expense 12.37
    Net Profit -2.01
    Net Profit Margin (%) -16.17
    Earnings Per Share (EPS) -3.08
    EBITDA -1.54
    Effective Tax Rate (%) 0.49
    Particulars SEP 2025 (Values in Cr)
    Revenue 12.43
    Operating Expense 12.42
    Net Profit 0.04
    Net Profit Margin (%) 0.32
    Earnings Per Share (EPS) 0.06
    EBITDA 0.51
    Effective Tax Rate (%) 50.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 11.48
    Operating Expense 11.44
    Net Profit 0.03
    Net Profit Margin (%) 0.26
    Earnings Per Share (EPS) 0.05
    EBITDA 0.54
    Effective Tax Rate (%) 25.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 12.99
    Operating Expense 12.87
    Net Profit 0.09
    Net Profit Margin (%) 0.69
    Earnings Per Share (EPS) 0.14
    EBITDA 0.70
    Effective Tax Rate (%) 37.50
    Particulars MAR 2026 (Values in Cr)
    Revenue 46.92
    Operating Expense 46.84
    Net Profit -1.94
    Net Profit Margin (%) -4.13
    Earnings Per Share (EPS) -2.97
    EBITDA -0.10
    Effective Tax Rate (%) -6.62
    Particulars MAR 2025 (Values in Cr)
    Revenue 51.42
    Operating Expense 51.05
    Net Profit 0.27
    Net Profit Margin (%) 0.52
    Earnings Per Share (EPS) 0.41
    EBITDA 2.62
    Effective Tax Rate (%) 37.20
    Particulars MAR 2024 (Values in Cr)
    Revenue 58.56
    Operating Expense 58.28
    Net Profit 0.42
    Net Profit Margin (%) 0.71
    Earnings Per Share (EPS) 0.65
    EBITDA 2.70
    Effective Tax Rate (%) 27.58
    Particulars MAR 2023 (Values in Cr)
    Revenue 66.89
    Operating Expense 65.76
    Net Profit 0.49
    Net Profit Margin (%) 0.73
    Earnings Per Share (EPS) 0.75
    EBITDA 2.45
    Effective Tax Rate (%) 28.35
    Particulars MAR 2022 (Values in Cr)
    Revenue 69.09
    Operating Expense 67.91
    Net Profit 0.82
    Net Profit Margin (%) 1.18
    Earnings Per Share (EPS) 1.26
    EBITDA 2.52
    Effective Tax Rate (%) 34.92
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 16.01
    ROE % 2.63
    ROCE % 5.32
    Total Debt to Total Equity 1.34
    EBITDA Margin 5.10
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 15.55
    ROE % 4.24
    ROCE % 6.51
    Total Debt to Total Equity 1.04
    EBITDA Margin 4.63
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 14.91
    ROE % 9.46
    ROCE % 11.42
    Total Debt to Total Equity 0.51
    EBITDA Margin 4.54
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 14.34
    ROE % 8.72
    ROCE % 12.25
    Total Debt to Total Equity 0.36
    EBITDA Margin 3.59
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 13.16
    ROE % 9.64
    ROCE % 11.52
    Total Debt to Total Equity 0.21
    EBITDA Margin 3.28
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1.79
    Total Assets 40.62
    Total Liabilities 40.62
    Total Equity 10.42
    Share Outstanding 0
    Price to Book Ratio 1.95
    Return on Assets (%) 0.66
    Return on Capital (%) 1.21
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.92
    Total Assets 40.25
    Total Liabilities 40.25
    Total Equity 10.12
    Share Outstanding 0
    Price to Book Ratio 2.67
    Return on Assets (%) 1.04
    Return on Capital (%) 1.82
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1.63
    Total Assets 43.49
    Total Liabilities 43.49
    Total Equity 9.70
    Share Outstanding 0
    Price to Book Ratio 4.63
    Return on Assets (%) 1.12
    Return on Capital (%) 3.86
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.50
    Total Assets 37.89
    Total Liabilities 37.89
    Total Equity 9.33
    Share Outstanding 0
    Price to Book Ratio 1.99
    Return on Assets (%) 2.06
    Return on Capital (%) 7.31
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.69
    Total Assets 32.20
    Total Liabilities 32.20
    Total Equity 8.56
    Share Outstanding 0
    Price to Book Ratio 1.61
    Return on Assets (%) 2.38
    Return on Capital (%) 8.58
    Particulars MAR 2025 (Values in Cr)
    Net Income 0.42
    Cash from Operations 4.04
    Cash from Investing 0.13
    Cash from Financing -3.08
    Net change in Cash 0.88
    Free Cash Flow 4.06
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.58
    Cash from Operations -8.93
    Cash from Investing 0.10
    Cash from Financing 8.23
    Net change in Cash -0.71
    Free Cash Flow -8.90
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.67
    Cash from Operations 1.78
    Cash from Investing -1.46
    Cash from Financing 0.06
    Net change in Cash 0.11
    Free Cash Flow 3.33
    Particulars MAR 2022 (Values in Cr)
    Net Income 1.22
    Cash from Operations -0.25
    Cash from Investing 0.00
    Cash from Financing 0.31
    Net change in Cash -0.06
    Free Cash Flow -0.23
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.86
    Cash from Operations -8.31
    Cash from Investing 0.15
    Cash from Financing -0.52
    Net change in Cash -8.78
    Free Cash Flow -8.31
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 42.42 17.60 2.05 325.08 23.12 43.00
    BLISS GVS PHARMA LTD 488.95 39.37 4.35 5194.80 118.35 552.90
    CIPLA LTD. 1450.00 32.73 3.40 117137.57 1165.55 1672.20
    FERMENTA BIOTECH LTD. 546.75 25.57 3.95 1609.14 256.40 551.25
    GLAXOSMITHKLINE PHARMA LT 2647.45 42.60 19.77 44849.40 2088.00 2935.85
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 42.42 29.66 5.46 325.08 23.12 43.00
    AMRUTANJAN HEALTH CARE LTD. 517.35 23.19 4.03 1495.69 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8173.90 106.82 23.41 20434.75 7630.00 9850.00
    BLISS GVS PHARMA LTD 488.95 52.92 4.49 5194.80 118.35 552.90

    Zenlabs Ethica Limited shareholding pattern

    Holding
    47.03%
    52.96%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    Zenlabs Ethica Limited Technicals Summary

    29.04 2.43 redarrow
    red-green-graph indicator
    8 Bearish
    8 Bullish
    • 5 Days 28.40
    • 26 Days 30.60
    • 10 Days 28.90
    • 50 Days 30.80
    • 12 Days 29.20
    • 100 Days 29.30
    • 20 Days 30.10
    • 200 Days 28.50
    27.51 PIVOT
    First Support 26.66 First Resistance 29.21 Second Support 24.96 Second Resistance 30.06 Third Support 24.11 Third Resistance 31.76
    RSI 42.59 ADX 41.70 MACD -1.38 Williams % R -61.08 Commodity Channel Index (CCI) -96.76
    Date 2026-08-04 Week 7384.00 Same Day 6289.00 Month 2812.00
    1 Year 1.24 3 Year 0.83
    Over 1 Month
    -20.36% down
    Over 1 Year
    -11.35% down
    Over 3 Months
    19.67% down
    Over 3 Years
    -11.98% down
    Over 6 Months
    46.96% down
    Over 5 Years
    -8.58% down

    Zenlabs Ethica Limited Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    29 Jul 2022 0.25 Interim 01 Aug 2022 Equity shares
    20 Sep 2017 0.25 Final 22 Sep 2017 Equity shares
    Ex-Date Ex-Bonus Ratio
    13 Oct 2018 11 Oct 2018 1:20

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Zenlabs Ethica Ltd?

    Answer Field

    Zenlabs Ethica Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 29.04 as on Aug 05 2026 03:16 PM.

    What is the Market Cap of Zenlabs Ethica Ltd Share?

    Answer Field

    The market cap of Zenlabs Ethica Ltd for NSE ₹ 0.00 & for BSE ₹ 18.90 as on Aug 05 2026 03:16 PM.

    What is the 52 Week High and Low of Zenlabs Ethica Ltd?

    Answer Field

    The 52 Week High and Low of Zenlabs Ethica Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 39.99 and ₹ 16.50.

    What is 1 year return for Zenlabs Ethica Ltd?

    Answer Field

    The 1 year returns on the stock has been -11.35%.

    What is the P/E Ratio of Zenlabs Ethica Ltd Share?

    Answer Field

    As on Aug 05 2026 03:16 PM the price-to-earnings (PE) ratio for Zenlabs Ethica Ltd share is -9.55.

    What is the PB ratio of Zenlabs Ethica Ltd Share?

    Answer Field

    As on Aug 05 2026 03:16 PM, the price-to-book (PB) ratio for Zenlabs Ethica Ltd share is 13.07.

    How to Buy Zenlabs Ethica Ltd Share?

    Answer Field

    You can trade in Zenlabs Ethica Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Zenlabs Ethica Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Zenlabs Ethica Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Zenlabs Ethica Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |